{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:54:04Z","timestamp":1768200844576,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00223-022-00952-6","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T02:04:12Z","timestamp":1644285852000},"page":"96-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bilateral Atypical Femur Fractures After Denosumab in a Bisphosphonate Naive Patient: A Case Report"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-7006","authenticated-orcid":false,"given":"Jeremy Keng Meng","family":"Goh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Suang Bee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin Choong Meng","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng Ai","family":"Png","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tet Sen","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"issue":"8","key":"952_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R et al (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383(8):743\u2013753. https:\/\/doi.org\/10.1056\/NEJMoa1916525","journal-title":"N Engl J Med"},{"issue":"1","key":"952_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1186\/s12885-019-6236-6","volume":"19","author":"M Takahashi","year":"2019","unstructured":"Takahashi M, Ozaki Y, Kizawa R et al (2019) Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review. BMC Cancer 19(1):980. https:\/\/doi.org\/10.1186\/s12885-019-6236-6","journal-title":"BMC Cancer"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O\u2019Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323. https:\/\/doi.org\/10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"952_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/812794","volume":"2015","author":"AA Patel","year":"2015","unstructured":"Patel AA, Ramanathan R, Kuban J, Willis MH (2015) Imaging findings and evaluation of metabolic bone disease. Adv Radiol 2015:1\u201321. https:\/\/doi.org\/10.1155\/2015\/812794","journal-title":"Adv Radiol"},{"issue":"11","key":"952_CR5","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1210\/jc.2013-1597","volume":"98","author":"HG Bone","year":"2013","unstructured":"Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, Mellstr\u00f6m D, Radominski SC, Reginster JY, Resch H, Ivorra JA, Roux C, Vittinghoff E, Daizadeh NS, Wang A, Bradley MN, Franchimont N, Geller ML, Wagman RB, Cummings SR, Papapoulos S (2013) The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab 98(11):4483\u20134492. https:\/\/doi.org\/10.1210\/jc.2013-1597","journal-title":"J Clin Endocrinol Metab"},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/249872","volume":"2013","author":"J Villiers","year":"2013","unstructured":"Villiers J, Clark DW, Jeswani T, Webster S, Hepburn AL (2013) An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab. Case Rep Rheumatol 2013:1\u20134. https:\/\/doi.org\/10.1155\/2013\/249872","journal-title":"Case Rep Rheumatol"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bone.2013.12.027","volume":"61","author":"RN Thompson","year":"2014","unstructured":"Thompson RN, Armstrong CL, Heyburn G (2014) Bilateral atypical femoral fractures in a patient prescribed denosumab\u2014a case report. Bone 61:44\u201347. https:\/\/doi.org\/10.1016\/j.bone.2013.12.027","journal-title":"Bone"},{"issue":"3","key":"952_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00774-014-0606-6","volume":"33","author":"KS Khow","year":"2014","unstructured":"Khow KS, Yong TY (2014) Atypical femoral fracture in a patient treated with denosumab. J Bone Miner Metab 33(3):355\u2013358. https:\/\/doi.org\/10.1007\/s00774-014-0606-6","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"952_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/17453674.2014.885355","volume":"85","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Aspenberg P (2014) Atypical fracture of the femur in a patient using denosumab\u2014a case report. Acta Orthop 85(1):6\u20137. https:\/\/doi.org\/10.3109\/17453674.2014.885355","journal-title":"Acta Orthop"},{"issue":"1","key":"952_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/17453674.2013.854668","volume":"85","author":"E Drampalos","year":"2013","unstructured":"Drampalos E, Skarpas G, Barbounakis N, Michos I (2013) Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop 85(1):3\u20135. https:\/\/doi.org\/10.3109\/17453674.2013.854668","journal-title":"Acta Orthop"},{"issue":"2","key":"952_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00198-015-3354-0","volume":"27","author":"SK Ramchand","year":"2015","unstructured":"Ramchand SK, Chiang CY, Zebaze RM, Seeman E (2015) Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Osteoporos Int 27(2):821\u2013825. https:\/\/doi.org\/10.1007\/s00198-015-3354-0","journal-title":"Osteoporos Int"},{"issue":"2","key":"952_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00198-015-3355-z","volume":"27","author":"J Selga","year":"2015","unstructured":"Selga J, Nu\u00f1ez J, Minguell J, Lalanza M, Garrido M (2015) Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review. Osteoporos Int 27(2):827\u2013832. https:\/\/doi.org\/10.1007\/s00198-015-3355-z","journal-title":"Osteoporos Int"},{"key":"952_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2018.1534576","author":"KH Lai","year":"2019","unstructured":"Lai KH, Chiang CY, Yang RS, Yang KC, Wu CC (2019) Conservative treatment of recurrent symptoms of an incomplete, atypical femoral fracture associated with glucocorticoid, bisphosphonate, and denosumab therapy in a patient with chronic obstructive pulmonary disease. Acta Clin Belg. https:\/\/doi.org\/10.1080\/17843286.2018.1534576","journal-title":"Acta Clin Belg"},{"key":"952_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229366","author":"J Tan","year":"2019","unstructured":"Tan J, Sano H, Poole K (2019) Antiresorptive-associated spontaneous fractures of both tibiae, followed by an atypical femur fracture during the sequential treatment with alendronate, denosumab then teriparatide. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2019-229366","journal-title":"BMJ Case Rep"},{"issue":"11","key":"952_CR15","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00198-020-05499-6","volume":"31","author":"H Piponov","year":"2020","unstructured":"Piponov H, Goldstein J, Eisenberg G (2020) Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis\u2014a case report. Osteoporos Int 31(11):2263\u20132267. https:\/\/doi.org\/10.1007\/s00198-020-05499-6","journal-title":"Osteoporos Int"},{"issue":"16","key":"952_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/nejmoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden D, Adachi J, Binkley N, Czerwinski E, Ferrari S et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543. https:\/\/doi.org\/10.1056\/nejmoa1607948","journal-title":"N Engl J Med"},{"issue":"3","key":"952_CR17","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.4158\/ep12367.cr","volume":"19","author":"R Paparodis","year":"2013","unstructured":"Paparodis R, Buehring B, Pelley E, Binkley N (2013) A case of an unusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract 19(3):e64\u2013e68. https:\/\/doi.org\/10.4158\/ep12367.cr","journal-title":"Endocr Pract"},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1359\/jbmr.090310","volume":"24","author":"PD Delmas","year":"2009","unstructured":"Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R (2009) Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res 24:1544\u20131551. https:\/\/doi.org\/10.1359\/jbmr.090310","journal-title":"J Bone Miner Res"},{"issue":"11","key":"952_CR19","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.injury.2016.09.031","volume":"47","author":"Y Iizuka","year":"2016","unstructured":"Iizuka Y, Iizuka H, Kaneko T, Mieda T, Takechi R, Suzuki H, Sorimachi Y, Suto T, Tachibana M, Yoneyama T, Omodaka T, Hashimoto S, Hamano N, Sakane H, Shimoyama D, Kohama I, Ohshima A, Nozaki T, Kamiyama M, Takagishi K (2016) Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients. Injury 47(11):2484\u20132489. https:\/\/doi.org\/10.1016\/j.injury.2016.09.031","journal-title":"Injury"},{"issue":"3","key":"952_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, Christiansen C, Grauer A, Kutilek S, Libanati C, McClung MR, Reid IR, Resch H, Siris E, Uebelhart D, Wang A, Weryha G, Cummings SR (2011) Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res 26(3):530\u2013537. https:\/\/doi.org\/10.1002\/jbmr.251","journal-title":"J Bone Miner Res"},{"issue":"5","key":"952_CR21","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595\u20131622. https:\/\/doi.org\/10.1210\/jc.2019-00221","journal-title":"J Clin Endocrinol Metab"},{"issue":"9999","key":"952_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 386(9999):1147\u20131155. https:\/\/doi.org\/10.1016\/S0140-6736(15)61120-5","journal-title":"Lancet"},{"issue":"5","key":"952_CR23","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1210\/clinem\/dgz295","volume":"105","author":"DM van de Laarschot","year":"2020","unstructured":"van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Gua\u00f1abens N, Eastell R, Ralston SH, Zillikens MC (2020) Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. J Clin Endocrinol Metab 105(5):1682\u20131699. https:\/\/doi.org\/10.1210\/clinem\/dgz295","journal-title":"J Clin Endocrinol Metab"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12891-016-1086-8","volume":"17","author":"G Toro","year":"2016","unstructured":"Toro G, Ojeda-Thies C, Calabr\u00f2 G, Toro G, Moretti A, Guerra GM, Caba-Doussoux P, Iolascon G (2016) Management of atypical femoral fracture: a scoping review and comprehensive algorithm. BMC Musculoskelet Disord 17:227. https:\/\/doi.org\/10.1186\/s12891-016-1086-8","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-00952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-022-00952-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-00952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T12:04:57Z","timestamp":1656072297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-022-00952-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s00223-022-00952-6","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Joyce Suang Bee Koh\u2014Moderator and facilitator honorarium from Amgen 2021 and received faculty honorarium from AOTrauma Asia\u2013Pacific 2021. Dr Alvin Choong Meng Ng\u2014Previously received speakers honoraria from Amgen. All other authors declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB: Local institutional review board (IRB) approval was waived for this study, as none required for case reports.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Patient consent was obtained for this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}